The online reference source for the interventional NeuroRadiology, Neurology and NeuroSurgery community
>Pipeline shield single antiplatelet therapy aneurysmal subarachnoid haemorrhage: multicentre experience
Pipeline shield with single antiplatelet therapy in aneurysmal subarachnoid haemorrhage: multicentre experience
The Pipeline embolisation Device with shield technology (PED-shield) is suggested to have reduced thrombogenicity. This reduced thrombogenicity may make it possible to use safely in the acute treatment of aneurysmal subarachnoid haemorrhage (aSAH) on single antiplatelet therapy (SAPT).
To evaluate the safety and efficacy of the off-label use of PED-shield with SAPT for the acute treatment of aSAH.